NFkappaB decoy oligo program (AnGes)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNFkappaB decoy oligo program (AnGes)
Drug Alias Nameinflammatory bowel disease therapy (AnGes)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnges Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnges Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A